A group of scientists from the Angiogenesis Unit of the Biomedical Research Centre of La Rioja (CIBIR) has succeeded in creating a vaccine, based on messenger RNA technology, that ...

The field of oncology has been revolutionized by the introduction of immune checkpoint inhibitors, with anti-PD-1 therapies offering durable responses in ...

High dietary inflammatory index (DII), which quantifies the inflammatory potential of diet, is associated with increased ...

The first thing that comes to mind with the word trained immunity is the immunological training every immune cell acquired during the entire lifespan of an ...

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

A common hay fever trigger could be treated by placing a "molecular shield" in the nose within five years. Scientists have ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

Vaccine experts have developed an antibody that, when applied to the nose, intercepts allergens before they can trigger a ...

A large-scale bibliometric analysis maps global research on hydrogels as next-generation drug delivery systems for cancer ...

That time of year is almost upon us, when millions of people in the UK succumb to pollen-induced sneezes, sniffles and itchy ...